BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38017611)

  • 21. Methylglyoxal induces peritoneal thickening by mesenchymal-like mesothelial cells in rats.
    Hirahara I; Ishibashi Y; Kaname S; Kusano E; Fujita T
    Nephrol Dial Transplant; 2009 Feb; 24(2):437-47. PubMed ID: 18790810
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of the RAS contributes to peritoneal fibrosis via dysregulation of low-density lipoprotein receptor.
    Liu J; Feng Y; Li N; Shao QY; Zhang QY; Sun C; Xu PF; Jiang CM
    Am J Physiol Renal Physiol; 2021 Mar; 320(3):F273-F284. PubMed ID: 33427062
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mesenchymal stem cells ameliorate experimental peritoneal fibrosis by suppressing inflammation and inhibiting TGF-β1 signaling.
    Ueno T; Nakashima A; Doi S; Kawamoto T; Honda K; Yokoyama Y; Doi T; Higashi Y; Yorioka N; Kato Y; Kohno N; Masaki T
    Kidney Int; 2013 Aug; 84(2):297-307. PubMed ID: 23486522
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preventive effect of Notch signaling inhibition by a gamma-secretase inhibitor on peritoneal dialysis fluid-induced peritoneal fibrosis in rats.
    Zhu F; Li T; Qiu F; Fan J; Zhou Q; Ding X; Nie J; Yu X
    Am J Pathol; 2010 Feb; 176(2):650-9. PubMed ID: 20056840
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HL156A, a novel AMP-activated protein kinase activator, is protective against peritoneal fibrosis in an in vivo and in vitro model of peritoneal fibrosis.
    Ju KD; Kim HJ; Tsogbadrakh B; Lee J; Ryu H; Cho EJ; Hwang YH; Kim K; Yang J; Ahn C; Oh KH
    Am J Physiol Renal Physiol; 2016 Mar; 310(5):F342-50. PubMed ID: 26661649
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of TGF-β1 Receptor Inhibitor GW788388 on the Epithelial to Mesenchymal Transition of Peritoneal Mesothelial Cells.
    Lho Y; Do JY; Heo JY; Kim AY; Kim SW; Kang SH
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33947038
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differentiation of bone marrow-derived cells into regenerated mesothelial cells in peritoneal remodeling using a peritoneal fibrosis mouse model.
    Sekiguchi Y; Hamada C; Ro Y; Nakamoto H; Inaba M; Shimaoka T; Io H; Koyanagi I; Aruga S; Inuma J; Kaneko K; Hotta Y; Margetts PJ; Mochizuki H; Horikoshi S; Tomino Y
    J Artif Organs; 2012 Sep; 15(3):272-82. PubMed ID: 22622710
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A protective role of nintedanib in peritoneal fibrosis through H19-EZH2-KLF2 axis via impeding mesothelial-to-mesenchymal transition.
    Zhong W; Fu J; Liao J; Ouyang S; Yin W; Liang Y; Liu K
    Int Urol Nephrol; 2024 Jun; 56(6):1987-1999. PubMed ID: 38097887
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic or pharmacologic blockade of enhancer of zeste homolog 2 inhibits the progression of peritoneal fibrosis.
    Shi Y; Tao M; Wang Y; Zang X; Ma X; Qiu A; Zhuang S; Liu N
    J Pathol; 2020 Jan; 250(1):79-94. PubMed ID: 31579944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blocking TGF-β1 by P17 peptides attenuates gastric cancer cell induced peritoneal fibrosis and prevents peritoneal dissemination in vitro and in vivo.
    Lv ZD; Zhao WJ; Jin LY; Wang WJ; Dong Q; Li N; Xu HM; Wang HB
    Biomed Pharmacother; 2017 Apr; 88():27-33. PubMed ID: 28092842
    [TBL] [Abstract][Full Text] [Related]  

  • 31. N-methylpiperazine-diepoxyovatodiolide ameliorates peritoneal fibrosis via suppressing TGF-β/Smad and JAK/STAT signaling pathway.
    Mo M; Zeng Y; Zeng Y; Li S; He X; Chen X; Luo Q; Liu M; Luo C; Dou X; Peng F; Long H
    Chem Biol Interact; 2023 Sep; 382():110589. PubMed ID: 37268199
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Therapeutic Potential of Human Umbilical Mesenchymal Stem Cells From Wharton's Jelly in the Treatment of Rat Peritoneal Dialysis-Induced Fibrosis.
    Fan YP; Hsia CC; Tseng KW; Liao CK; Fu TW; Ko TL; Chiu MM; Shih YH; Huang PY; Chiang YC; Yang CC; Fu YS
    Stem Cells Transl Med; 2016 Feb; 5(2):235-47. PubMed ID: 26718649
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of CIP4 in high glucose induced epithelial--mesenchymal transition of rat peritoneal mesothelial cells.
    Zhang J; Bi M; Zhong F; Jiao X; Zhang D; Dong Q
    Ren Fail; 2013 Aug; 35(7):989-95. PubMed ID: 23819628
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA-302c modulates peritoneal dialysis-associated fibrosis by targeting connective tissue growth factor.
    Li X; Liu H; Sun L; Zhou X; Yuan X; Chen Y; Liu F; Liu Y; Xiao L
    J Cell Mol Med; 2019 Apr; 23(4):2372-2383. PubMed ID: 30693641
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preventing peritoneal membrane fibrosis in peritoneal dialysis patients.
    Zhou Q; Bajo MA; Del Peso G; Yu X; Selgas R
    Kidney Int; 2016 Sep; 90(3):515-24. PubMed ID: 27282936
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Paracrine effects of transplanted mesothelial cells isolated from temperature-sensitive SV40 large T-antigen gene transgenic rats during peritoneal repair.
    Kanda R; Hamada C; Kaneko K; Nakano T; Wakabayashi K; Hara K; Io H; Horikoshi S; Tomino Y
    Nephrol Dial Transplant; 2014 Feb; 29(2):289-300. PubMed ID: 24081857
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Calcitriol decreases TGF-β1 and angiotensin II production and protects against chlorhexide digluconate-induced liver peritoneal fibrosis in rats.
    Lee CJ; Subeq YM; Lee RP; Liou HH; Hsu BG
    Cytokine; 2014 Jan; 65(1):105-18. PubMed ID: 24210651
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A pathogenetic role for endothelin-1 in peritoneal dialysis-associated fibrosis.
    Busnadiego O; Loureiro-Álvarez J; Sandoval P; Lagares D; Dotor J; Pérez-Lozano ML; López-Armada MJ; Lamas S; López-Cabrera M; Rodríguez-Pascual F
    J Am Soc Nephrol; 2015 Jan; 26(1):173-82. PubMed ID: 25012164
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pleiotrophin triggers inflammation and increased peritoneal permeability leading to peritoneal fibrosis.
    Yokoi H; Kasahara M; Mori K; Ogawa Y; Kuwabara T; Imamaki H; Kawanishi T; Koga K; Ishii A; Kato Y; Mori KP; Toda N; Ohno S; Muramatsu H; Muramatsu T; Sugawara A; Mukoyama M; Nakao K
    Kidney Int; 2012 Jan; 81(2):160-9. PubMed ID: 21881556
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MiR-200a negatively regulates TGF-β
    Guo R; Hao G; Bao Y; Xiao J; Zhan X; Shi X; Luo L; Zhou J; Chen Q; Wei X
    Am J Physiol Renal Physiol; 2018 Jun; 314(6):F1087-F1095. PubMed ID: 29357421
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.